XML 46 R36.htm IDEA: XBRL DOCUMENT
v3.21.2

Restructuring and Other (Tables) | 3 Months Ended
--- | ---
Jun. 30, 2021
Restructuring and Related Activities [Abstract] |
Restructuring and Other | Restructuring and other includes restructuring and severance costs, certain transaction and related costs, and certain unusual items, when applicable. During the three months ended June 30, 2021 and 2020, the Company also incurred certain other unusual charges related to the COVID-19 global pandemic. The following table sets forth restructuring and other and COVID-19 related charges and the statement of operations line items they are included in for the three months ended June 30, 2021 and 2020:
|  |  | Three Months Ended
|  |  | June 30,
|  |  |  |  | 2021 |  | 2020
|  |  |  |  | (Amounts in millions)
Restructuring and other: |  |  |  |  |  |  |
Severance(1) |  |  |  |  | $ | 2.4 |  |  | $ | 2.2 |
COVID-19 related charges included in restructuring and other(2) |  |  |  |  | 0.3 |  |  | 0.5 |
Transaction and related costs(3) |  |  |  |  | 0.5 |  |  | 0.3 |
Total Restructuring and Other |  |  |  |  | 3.2 |  |  | 3.0 |
COVID-19 related charges not included in restructuring and other, included in: |  |  |  |  |  |  |
Direct operating expense(4) |  |  |  |  | 1.6 |  |  | 5.7 |
Distribution and marketing expense(4) |  |  |  |  | — |  |  | 4.7 |
Total restructuring and other and COVID-19 related charges |  |  |  |  | $ | 4.8 |  |  | $ | 13.4 |
_______________________ (1)Severance costs in the three months ended June 30, 2021 and 2020 were primarily related to restructuring activities in connection with cost-saving initiatives and recent acquisitions. (2)During the three months ended June 30, 2021, the Company has incurred certain costs primarily related to incremental costs required to adhere to health and safety protocols and other incremental costs associated with the COVID-19 global pandemic. In the three months ended June 30 2020, these costs were primarily related to transitioning the Company to a remote-work environment and other incremental costs associated with the COVID-19 global pandemic. (3)Transaction and related costs in the three months ended June 30, 2021 and 2020 reflect transaction, integration and legal costs associated with certain strategic transactions, restructuring activities and legal matters. (4)In connection with the disruptions associated with the COVID-19 global pandemic and measures to prevent its spread and mitigate its effects both domestically and internationally, and the related economic disruption, including the worldwide closure of theaters, international travel restrictions and the pausing of motion picture and television productions, during the three months ended June 30, 2021 and 2020 the Company incurred certain incremental costs which were expensed in the period. The costs included in direct operating expense primarily represent incremental costs associated with the pausing and restarting of productions including certain cast and crew, idle facilities and equipment costs resulting from circumstances associated with the COVID-19 global pandemic, net of insurance recoveries. In addition, the costs included in distribution and marketing expense primarily consist of contractual marketing spends for film releases and events that have been canceled or delayed and will provide no economic benefit. The Company is in the process of seeking additional insurance recovery for some of these costs. The ultimate amount of insurance recovery cannot be estimated at this time. Changes in the restructuring and other severance liability were as follows for the three months ended June 30, 2021 and 2020:
| Three Months Ended
| June 30,
| 2021 |  | 2020 |  |
| (Amounts in millions)
Severance liability |  |  |  |  |
Beginning balance | $ | 5.7 |  |  | $ | 11.1 |  |  |
Accruals | 2.4 |  |  | 2.2 |  |  |
Severance payments | (3.8) |  |  | (5.3) |  |  |
Ending balance(1) | $ | 4.3 |  |  | $ | 8.0 |  |  |
_______________________ (1)As of June 30, 2021, the remaining severance liability of approximately $4.3 million is expected to be paid in the next 12 months.

X
- References No definition available. + Details
Name: | us-gaap_RestructuringAndRelatedActivitiesAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of costs incurred for restructuring including, but not limited to, exit and disposal activities, remediation, implementation, integration, asset impairment, and charges against earnings from the write-down of assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 5.P.3) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140864-122747 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6394359&loc=d3e17939-110869 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 420 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.P.4) -URI http://asc.fasb.org/extlink&oid=115931487&loc=d3e140904-122747 + Details
Name: | us-gaap_ScheduleOfRestructuringAndRelatedCostsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration